Richard Falivena, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 2 Stone Harbor Blvd, Cape May Court House, NJ 08210 Phone: 609-463-2482 Fax: 609-463-2318 |
Dr. Jeffrey P Tenner, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 217 N Main St, Suite 104, Cape May Court House, NJ 08210 Phone: 609-463-1488 Fax: 609-463-4881 |
Dr. Rafael Attiya, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 15 Village Dr, Cape May Court House, NJ 08210 Phone: 609-463-8887 Fax: 609-463-1116 |
Paul L Odonnell, DO Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 217 N Main St, Suite 104, Cape May Court House, NJ 08210 Phone: 609-463-1488 Fax: 609-463-4881 |
Richard Michael Lawinski, MD Surgery Medicare: Medicare Enrolled Practice Location: 9 Broadway, Unit B, Cape May Court House, NJ 08210 Phone: 609-463-1000 Fax: 609-463-8301 |
Dr. Donald C Tomasello, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 217 N Main St, Suite 104, Cape May Court House, NJ 08210 Phone: 609-463-8600 Fax: 609-463-8602 |
Joseph Charles Benedetto, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 223 N Main St, Cape May Court House, NJ 08210 Phone: 609-463-2273 Fax: 609-778-2358 |
Vinayak Mahadeo Sabnis, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 Stone Harbor Blvd, Suite A, Cape May Court House, NJ 08210 Phone: 609-465-2221 Fax: 609-465-4939 |
News Archive
A small decrease in UK Tuberculosis (TB) cases in 2007, compared with 2006, was reported by the Health Protection Agency today when provisional UK figures were released for World TB Day, but experts warn the number is still too high.
A new report from the Cancer Research UK, released this week, says that England would not be declared smoke free by 2030 as earlier projected if the current smoking trends continue. This target of declaring England smoke free by 2030 was set last year, and researchers state that there is still much work to be done.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
Studying how our bodies metabolize lipids such as fatty acids, triglycerides, and cholesterol can teach us about cardiovascular disease, diabetes, and other health problems, as well as reveal basic cellular functions.
› Verified 2 days ago